The method of 2D cell culture is not a true reflection of the physiological cell environment where cells connect to other cells and, also to the extracellular matrix (ECM). Therefore some of the processes studied in 2D culture such as gene expression, apoptosis and importantly drug uptake and toxicity may not be directly transferable to in vivo experiments. HCS Pharma has developed a physiological and natural hydroscaffold, based on Hyaluronic Acid (HA) biofunctionalized with ECM components as collagens I, IV or VI, fibronectin and other molecules of interest. We will present the use of this scaffold on an automated platform, with the development of a 3D cell model for steatosis and phospholipidosis assessment as an example. Automated HepG2 cells seeding, medium renewal, spheroids treatment, fixation, staining and imaging will be discussed.

BIOMIMESYS® represents a new generation of mimetic hydroscaffold for 3D cell culture. Available in a ready-to-use format it enables the culture of cells under physiological conditions that are representative of the microenvironment found in whole tissues. The highly porous nature of the hydroscaffold allows the rapid uptake of nutrients, oxygen, etc. into the cells to create a reproducible study model for all downstream analytical techniques used with 3D cell culture.

Biomimesys® scaffolds technology is an innovative tool, closely mimeting the ECM matrix for relevant 3D cell culture allowing advanced drug discovery, ADME-Tox profiling and disease modelling. It is physiological, easy to use and compatible with all standard analysis methods (fluorescent plate reader, microscopy, Immunofluorescence, direct cell lysis for nucleic acids and protein extraction, histology).

View and download on Slideshare (low quality) : https://www.slideshare.net/hcspharma/biomimesys-hydroscaffold-for-3d-cell-culture-automation-of-the-processes-from-cell-seeding-to-imaging

Ask for high quality link  by putting your email below


gregory

gregory

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.

2 Comments

HCS pharma in ELRIGfr Strasbourg! | HCS Pharma · May 22, 2018 at 12:20 pm

[…] first poster is about BIOMIMESYS® hydroscaffold for 3D cell culture and the compatibility with automation; the plates can be seeded, treated […]

Our last experience in ELRIG Fr and EUROoC meetings! | HCS Pharma · June 12, 2018 at 12:01 pm

[…] presented two posters there, one about BIOMIMESYS hydroscaffold and the other about neurotoxicity […]

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: